Icosapent ethyl for reducing the risk of cardiovascular events.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 30, doi. 10.1002/psb.2045
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2023 AND VI 34 AND IP 2
Results: 8
1
2
Rimegepant for the prevention and treatment of migraine.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 28, doi. 10.1002/psb.2044
- By:
- Publication type:
- Article
3
Realising the potential of faecal microbiota transplant.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 22, doi. 10.1002/psb.2043
- By:
- Publication type:
- Article
4
Prescribing Skills Assessment.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 21, doi. 10.1002/psb.2042
- Publication type:
- Article
5
Improving antimicrobial stewardship in general practice.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 17, doi. 10.1002/psb.2041
- By:
- Publication type:
- Article
6
NICE on the diagnosis and management of osteoarthritis.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 15, doi. 10.1002/psb.2040
- By:
- Publication type:
- Article
7
Managing patients with tuberculosis in primary care.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 9, doi. 10.1002/psb.2039
- By:
- Publication type:
- Article
8
Medicalising normal life has its risks.
- Published in:
- Prescriber, 2023, v. 34, n. 2, p. 4, doi. 10.1002/psb.2038
- Publication type:
- Article